carbamates and cobicistat

carbamates has been researched along with cobicistat in 48 studies

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's47 (97.92)24.3611
2020's1 (2.08)2.80

Authors

AuthorsStudies
German, P; Hui, J; Jain, A; Kearney, BP; Mathias, AA; Murray, BP; Warren, D; Wei, L; West, S1
Chuck, SL; Cohen, C; DeJesus, E; Elion, R; Kearney, BP; Liu, HC; Ramanathan, S; Rashbaum, B; Ruane, P; Shamblaw, D; Warren, DR; Yale, K1
Chuck, SL; Cohen, C; Elion, R; Gathe, J; Hawkins, T; Kearney, BP; Liu, HC; Mathias, AA; Shalit, P; Warren, DR1
Andrews, J; German, P; Hepner, M; Kearney, BP; Liu, HC; Mathias, A; Szwarcberg, J1
Cheng, AK; DeJesus, E; Gathe, J; Henry, K; Kearney, BP; Molina, JM; Ramanathan, S; Rockstroh, JK; Szwarcberg, J; Wei, X; White, K; Yale, K1
Cheng, AK; Cohen, C; DeJesus, E; Gallant, JE; Kearney, BP; Liu, HC; Mills, A; Quirk, E; Sax, PE; Szwarcberg, J; White, K; Wohl, D; Yale, K; Zhong, L; Zolopa, A1
Debyser, Z; Schrijvers, R2
Lepist, EI; Maclennan, K; Murray, B; Phan, TK; Ray, AS; Roy, A; Tong, L1
Pommer, P1
Haberl, A; von Hentig, N1
Temesgen, Z2
Belavic, JM1
Abram, M; Cheng, AK; DeJesus, E; Fordyce, MW; Gathe, J; Henry, K; Molina, JM; Plummer, A; Ramanathan, S; Rockstroh, JK; Szwarcberg, J; Wei, X1
Priano, J; Schafer, JJ; Shah, BM; Squires, KE1
Cahn, P; Sued, O1
Andrade-Villanueva, J; Antunes, F; Arastéh, K; Callebaut, C; Cheng, AK; Chetchotisakd, P; DeJesus, E; Fehr, J; Gallant, JE; Koenig, E; Liu, Y; Moyle, G; Rhee, MS; Rizzardini, G; Szwarcberg, J; Zhong, L1
Bruce, RD; Custodio, JM; Friedland, GH; Kearney, BP; Ramanathan, S; Rhee, MS; Wei, LX; Winkle, P1
Cheng, A; Kearney, BP; Koziara, J; Mathias, A; Ramanathan, S; Shen, G; Wei, X1
Bam, RA; Birkus, G; Cihlar, T; Hao, J; Lepist, EI; Ray, AS; Stray, KM; Yant, SR1
Aldir, I; Horta, A; Serrado, M1
Bruce, RD; Custodio, JM; Friedland, GH; Kearney, BP; Ramanathan, S; Rhee, MS; Wei, X; Winkle, P1
Deeks, ED1
Andrews, J; Cheng, A; Custodio, JM; Hao, J; Kearney, BP; Lepist, EI; Ling, KH; Ramanathan, S; Ray, AS; Wang, H1
Callebaut, C; Chau, J; Choi, YC; Desai, MC; Hong, A; Lee, MS; Liu, H; Murray, BP; Rhodes, GR; Stray, KM; Strickley, RG; Swaminathan, S; Tong, L; Tsai, LK; Vivian, R; Wang, J; Xu, L1
Ikeda, A; Irie, S; Ishikawa, T; Kimura, M; Matsuki, S; Nishino, N; Shiomi, M1
Hillewaert, V; Hoetelmans, RM; Iterbeke, K; Kakuda, TN; Opsomer, M; Petrovic, R; Timmers, M; Van De Casteele, T1
Bannister, R; Birkus, G; Cihlar, T; Hao, J; Huang, J; Huang, Y; Kosaka, A; Lepist, EI; Murray, BP; Ray, AS; Zhang, X1
Hsiao, CB; Ma, Q; Sawyer, JR1
Ayala-Sims, VA; Fulco, PP1
Capetti, A; Rizzardini, G1
Antela, A; Domingo, P; Garner, W; Girard, PM; Guyer, B; Henry, K; Markowitz, M; Mills, A; Nguyen, T; Piontkowsky, D; Pozniak, A; Stellbrink, HJ; White, K1
Arribas, JR; Di Perri, G; Ebrahimi, R; Gathe, J; Nguyen, T; Pialoux, G; Piontkowsky, D; Reynes, J; Tebas, P; White, K1
Hoetelmans, RM; Kakuda, TN; Neujens, M; Opsomer, M; Petrovic, R; Salih, H; Van De Casteele, T1
Bruzzone, B; Di Biagio, A; Gustinetti, G; Prinapori, R; Sticchi, L; Taramasso, L; Viscoli, C1
Acosta, EP; Delille, C; Larson, KB; Otofokun, I; Wang, K1
Abram, ME; Andrade-Villanueva, JF; Beraud, C; Cheng, AK; Fisher, M; Graham, H; Liu, Y; Post, FA; Rhee, MS; Szwarcberg, J; Winston, J1
Khoo, S; Lewis, J; Nsutebu, EN; Turtle, L1
Baeten, JM; Wyatt, C1
Andrade-Villanueva, J; Callebaut, C; Cao, H; Cheng, AK; Crofoot, G; Custodio, JM; DeJesus, E; Fordyce, MW; Koenig, E; Martin, H; McCallister, S; Molina, JM; Oka, S; Plummer, A; Podzamczer, D; Post, F; Pozniak, A; Saag, M; Sax, PE; Thompson, M; Trottier, B; Wohl, D; Yin, MT; Zhong, L1
Abram, ME; Andrade-Villanueva, JF; Antunes, F; Arastéh, K; Cao, H; Chetchotisakd, P; DeJesus, E; Fehr, J; Gallant, JE; Koenig, E; Liu, HC; Rizzardini, G; Szwarcberg, J1
Burger, DM; Colbers, EP; de Kanter, CT; Drenth, JP; Smolders, EJ; Velthoven-Graafland, K1
Chao, CM; Hsueh, PR; Lai, CC1

Reviews

10 review(s) available for carbamates and cobicistat

ArticleYear
Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.
    Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:13

    Topics: Adenine; Anti-HIV Agents; Carbamates; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cobicistat; Deoxycytidine; Drug Combinations; Drug Resistance, Multiple, Viral; Emtricitabine; HIV Infections; Humans; Organophosphonates; Quinolones; Tenofovir; Thiazoles

2012
Safety of pharmacoenhancers for HIV therapy.
    Expert review of clinical pharmacology, 2012, Volume: 5, Issue:5

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; Cobicistat; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Discovery; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; Thiazoles; Treatment Outcome

2012
Cobicistat-boosted elvitegravir-based fixed-dose combination antiretroviral therapy for HIV infection.
    Drugs of today (Barcelona, Spain : 1998), 2012, Volume: 48, Issue:12

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; Cobicistat; Drug Approval; Drug Combinations; Drug Interactions; Drug Resistance, Viral; HIV Infections; HIV Integrase Inhibitors; Humans; Patient Safety; Quinolones; Thiazoles

2012
Cobicistat: a new boost for the treatment of human immunodeficiency virus infection.
    Pharmacotherapy, 2013, Volume: 33, Issue:10

    Topics: Anti-HIV Agents; Carbamates; Cobicistat; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; HIV Infections; Humans; Ritonavir; Thiazoles

2013
Single-tablet regimens in HIV: does it really make a difference?
    Current medical research and opinion, 2014, Volume: 30, Issue:1

    Topics: Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Emtricitabine; HIV Infections; HIV-1; Humans; Nitriles; Organophosphonates; Pyrimidines; Quinolones; Reverse Transcriptase Inhibitors; Rilpivirine; Tablets; Tenofovir; Thiazoles

2014
Cobicistat: a review of its use as a pharmacokinetic enhancer of atazanavir and darunavir in patients with HIV-1 infection.
    Drugs, 2014, Volume: 74, Issue:2

    Topics: Atazanavir Sulfate; Carbamates; Cobicistat; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Drug Synergism; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Oligopeptides; Pyridines; Sulfonamides; Thiazoles

2014
Cobicistat : a new opportunity in the treatment of HIV disease?
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:9

    Topics: Anti-HIV Agents; Carbamates; Clinical Trials as Topic; Cobicistat; Cost-Benefit Analysis; Drug Combinations; Health Care Costs; HIV Infections; Humans; Thiazoles; Treatment Outcome

2014
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?
    Recent patents on anti-infective drug discovery, 2014, Volume: 9, Issue:1

    Topics: Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Combinations; Emtricitabine; HIV Infections; HIV-1; Humans; Patents as Topic; Phosphorous Acids; Quinolones; Thiazoles

2014
Pharmacokinetic enhancers in HIV therapeutics.
    Clinical pharmacokinetics, 2014, Volume: 53, Issue:10

    Topics: Anti-HIV Agents; Carbamates; Cobicistat; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Ritonavir; Thiazoles

2014
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:5

    Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Carbamates; Cobicistat; COVID-19 Drug Treatment; Darunavir; Dibenzothiepins; Drug Combinations; Drug Therapy, Combination; Humans; Imidazoles; Indoles; Iran; Lopinavir; Morpholines; Pyrazines; Pyridones; Pyrrolidines; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2; Sofosbuvir; Treatment Outcome; Triazines; Valine

2021

Trials

17 trial(s) available for carbamates and cobicistat

ArticleYear
Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection.
    AIDS (London, England), 2011, Mar-27, Volume: 25, Issue:6

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Cobicistat; Cyclopropanes; Deoxycytidine; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Organophosphonates; Patient Compliance; Patient Selection; Quinolones; Tenofovir; Thiazoles; Treatment Outcome

2011
Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection.
    AIDS (London, England), 2011, Sep-24, Volume: 25, Issue:15

    Topics: Adenine; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; CD4 Lymphocyte Count; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; RNA, Viral; Tenofovir; Thiazoles; Treatment Outcome

2011
Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function.
    Journal of acquired immune deficiency syndromes (1999), 2012, Sep-01, Volume: 61, Issue:1

    Topics: Adult; Carbamates; Cobicistat; Cohort Studies; Creatinine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Metabolic Clearance Rate; Placebos; Thiazoles

2012
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-
    Lancet (London, England), 2012, Jun-30, Volume: 379, Issue:9835

    Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Quinolones; Ritonavir; Tenofovir; Thiazoles

2012
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.
    Lancet (London, England), 2012, Jun-30, Volume: 379, Issue:9835

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Cobicistat; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Quinolones; Tenofovir; Thiazoles

2012
A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results
    Journal of acquired immune deficiency syndromes (1999), 2013, Apr-15, Volume: 62, Issue:5

    Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Atazanavir Sulfate; Bilirubin; Bone Density; Carbamates; Cobicistat; Confidence Intervals; Creatinine; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Oligopeptides; Organophosphonates; Pyridines; Quinolones; Ritonavir; RNA, Viral; Tenofovir; Thiazoles; Triglycerides

2013
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
    The Journal of infectious diseases, 2013, Volume: 208, Issue:1

    Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Tenofovir; Thiazoles; Treatment Outcome; Viral Load

2013
Pharmacokinetics of once-daily boosted elvitegravir when administered in combination with acid-reducing agents.
    Journal of acquired immune deficiency syndromes (1999), 2013, Sep-01, Volume: 64, Issue:1

    Topics: Adolescent; Adult; Antacids; Anti-HIV Agents; Area Under Curve; Carbamates; Cobicistat; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinolones; Thiazoles

2013
Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:6

    Topics: Adult; Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carbamates; CHO Cells; Cobicistat; Cricetulus; Dogs; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Madin Darby Canine Kidney Cells; Male; Neoplasm Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pyrimidines; Quinolones; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides; Thiazoles

2014
Effects of a protein-rich drink or a standard meal on the pharmacokinetics of elvitegravir, cobicistat, emtricitabine and tenofovir in healthy Japanese male subjects: a randomized, three-way crossover study.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:6

    Topics: Adenine; Adult; Anti-HIV Agents; Asian People; Beverages; Carbamates; Cobicistat; Cross-Over Studies; Deoxycytidine; Dietary Proteins; Drug Combinations; Emtricitabine; Food-Drug Interactions; Humans; Male; Middle Aged; Organophosphonates; Quinolones; Tenofovir; Thiazoles; Young Adult

2014
Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:8

    Topics: Adult; Biological Availability; Carbamates; Cobicistat; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Drug Combinations; Female; Healthy Volunteers; HIV Protease Inhibitors; Humans; Male; Middle Aged; Ritonavir; Sulfonamides; Thiazoles; Young Adult

2014
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week r
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Quinolones; Reverse Transcriptase Inhibitors; Tenofovir; Thiazoles; Viral Load

2014
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results o
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:7

    Topics: Adenine; Adult; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Protease Inhibitors; Quinolones; Ritonavir; Tenofovir; Thiazoles; Viral Load

2014
Bioequivalence of a darunavir/cobicistat fixed-dose combination tablet versus single agents and food effect in healthy volunteers.
    Antiviral therapy, 2014, Volume: 19, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Carbamates; Cobicistat; Darunavir; Drug Combinations; Drug Monitoring; Female; Food; Healthy Volunteers; Humans; Male; Middle Aged; Sulfonamides; Therapeutic Equivalency; Thiazoles; Young Adult

2014
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
    Lancet (London, England), 2015, Jun-27, Volume: 385, Issue:9987

    Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Arthralgia; Bone Density; Carbamates; CD4 Lymphocyte Count; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Combinations; Emtricitabine; Female; Headache; HIV Infections; Humans; Kidney; Male; Nausea; Organophosphonates; Quinolones; Respiration Disorders; Sleep Initiation and Maintenance Disorders; Tenofovir; Thiazoles; Treatment Outcome; Viral Load

2015
Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results.
    Journal of acquired immune deficiency syndromes (1999), 2015, Jul-01, Volume: 69, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; RNA, Viral; Tenofovir; Thiazoles; Viral Load

2015
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat.
    The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Cobicistat; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Female; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Pyrrolidines; Ritonavir; Valine; Young Adult

2017

Other Studies

21 other study(ies) available for carbamates and cobicistat

ArticleYear
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity.
    Clinical pharmacology and therapeutics, 2010, Volume: 87, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Carbamates; Cobicistat; Cohort Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Female; Humans; Isoenzymes; Male; Midazolam; Middle Aged; Pharmaceutical Preparations; Thiazoles; Young Adult

2010
Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitro.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Adenine; Alanine; Caco-2 Cells; Carbamates; Cobicistat; HIV Protease Inhibitors; Humans; Intestinal Absorption; Tenofovir; Thiazoles

2012
[A single tablet against HIV: new combination preparation improves therapy].
    Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:34-35

    Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Cobicistat; Cyclopropanes; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Emtricitabine; Glomerular Filtration Rate; HIV Infections; Humans; Oligopeptides; Organophosphonates; Pyridines; Quinolones; Randomized Controlled Trials as Topic; Ritonavir; Tenofovir; Thiazoles; Viral Load

2012
FDA approves new 4-drug once-a-day HIV treatment.
    AIDS policy & law, 2012, Volume: 27, Issue:11

    Topics: Adenine; Carbamates; Cobicistat; Deoxycytidine; Drug Administration Schedule; Drug Approval; Drug Combinations; Emtricitabine; HIV Infections; Humans; Organophosphonates; Quinolones; Tenofovir; Thiazoles; United States; United States Food and Drug Administration

2012
A 4-drug combination (Stribild) for HIV.
    The Medical letter on drugs and therapeutics, 2012, Nov-26, Volume: 54, Issue:1404

    Topics: Adenine; Anti-HIV Agents; Carbamates; Clinical Trials as Topic; Cobicistat; Deoxycytidine; Double-Blind Method; Drug Approval; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Viral; Emtricitabine; HIV; HIV Infections; Humans; Organophosphonates; Quinolones; Randomized Controlled Trials as Topic; Tenofovir; Thiazoles; United States; United States Food and Drug Administration

2012
Drug updates and approvals: 2012 in review.
    The Nurse practitioner, 2013, Feb-10, Volume: 38, Issue:2

    Topics: Acetanilides; Adenine; Antibodies, Monoclonal, Humanized; Benzazepines; Carbamates; Cobicistat; Deoxycytidine; Drug Approval; Drug Combinations; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Fatty Alcohols; Humans; Mifepristone; Nicotinic Acids; Nurse Practitioners; Organophosphonates; Phosphatidylglycerols; Prednisone; Proteins; Pyrimidines; Quinolones; Ranibizumab; Tenofovir; Thiazoles; United States; United States Food and Drug Administration

2013
Boosting HIV treatment options: good news, new challenges.
    The Journal of infectious diseases, 2013, Volume: 208, Issue:1

    Topics: Adenine; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Tenofovir; Thiazoles

2013
The pharmacokinetic and pharmacodynamic interactions between buprenorphine/naloxone and elvitegravir/cobicistat in subjects receiving chronic buprenorphine/naloxone treatment.
    Journal of acquired immune deficiency syndromes (1999), 2013, Aug-01, Volume: 63, Issue:4

    Topics: Adult; Anti-Retroviral Agents; Area Under Curve; Buprenorphine; Carbamates; Cobicistat; Drug Interactions; Female; HIV Infections; HIV Seronegativity; Humans; Male; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Quinolones; Thiazoles

2013
Cobicistat, a pharmacoenhancer for HIV treatments.
    Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49, Issue:4

    Topics: Anti-HIV Agents; Carbamates; Cobicistat; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; HIV Infections; Humans; Thiazoles

2013
Evaluation of the effect of cobicistat on the in vitro renal transport and cytotoxicity potential of tenofovir.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Adenine; Adult; Anti-HIV Agents; Carbamates; Cell Line; Cobicistat; Drug Interactions; Humans; In Vitro Techniques; Kidney; Male; Multidrug Resistance-Associated Proteins; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Organic Cation Transporter 2; Organophosphonates; Tenofovir; Thiazoles

2013
[ First integrase inhibitor based single tablet regimen].
    MMW Fortschritte der Medizin, 2013, Jun-13, Volume: 155 Suppl 1

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Carbamates; Cobicistat; Deoxycytidine; Drug Approval; Drug Combinations; Emtricitabine; HIV Infections; HIV Integrase Inhibitors; Humans; Organophosphonates; Quinolones; Tenofovir; Thiazoles; Treatment Outcome

2013
Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Adult; Anti-HIV Agents; Area Under Curve; Carbamates; Cobicistat; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Quinolones; Thiazoles

2013
Cobicistat + elvitegravir + emtricitabine + tenofovir. Two new drugs, but no progress.
    Prescrire international, 2013, Volume: 22, Issue:142

    Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV-1; Humans; Organophosphonates; Quinolones; Tenofovir; Thiazoles

2013
Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350).
    Bioorganic & medicinal chemistry letters, 2014, Feb-01, Volume: 24, Issue:3

    Topics: Carbamates; Cobicistat; Cytochrome P-450 CYP3A Inhibitors; Diamines; Enzyme Activation; Molecular Structure; Structure-Activity Relationship; Thiazoles

2014
Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.
    Kidney international, 2014, Volume: 86, Issue:2

    Topics: Animals; Biological Transport, Active; Carbamates; Cell Line; Cells, Cultured; CHO Cells; Cimetidine; Cobicistat; Creatinine; Cricetulus; Dogs; HEK293 Cells; Humans; Kidney Tubules; Kinetics; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Organic Cation Transporter 2; Recombinant Proteins; Thiazoles

2014
Single-tablet, once-daily treatment regimens for HIV.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:4

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Cobicistat; Cyclopropanes; Cytochrome P-450 CYP3A Inhibitors; Deoxycytidine; Drug Combinations; Emtricitabine; HIV Infections; HIV Integrase Inhibitors; HIV Reverse Transcriptase; Humans; Nitriles; Organophosphonates; Pyrimidines; Quinolones; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Thiazoles

2014
Sustained virological response after taking crushed elvitegravir-cobicistat-emtricitabine-tenofovir tablets.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014, May-15, Volume: 71, Issue:10

    Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Organophosphonates; Powders; Quinolones; Tablets; Tenofovir; Thiazoles; Viral Load

2014
Switching STRATEGIES in HIV treatment.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:7

    Topics: Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Male; Organophosphonates; Protease Inhibitors; Quinolones; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Thiazoles

2014
Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairment.
    Journal of acquired immune deficiency syndromes (1999), 2015, Mar-01, Volume: 68, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Carbamates; Cobicistat; Cohort Studies; Deoxycytidine; Emtricitabine; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Quinolones; Renal Insufficiency; Tenofovir; Thiazoles; Treatment Outcome

2015
A case of iatrogenic adrenal suppression after co-administration of cobicistat and fluticasone nasal drops.
    AIDS (London, England), 2014, Nov-13, Volume: 28, Issue:17

    Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Androstadienes; Carbamates; Cobicistat; Drug Interactions; Enzyme Inhibitors; Fluticasone; Humans; Hydrocortisone; Iatrogenic Disease; Male; Thiazoles

2014
Tenofovir alafenamide for HIV infection: is less more?
    Lancet (London, England), 2015, Jun-27, Volume: 385, Issue:9987

    Topics: Adenine; Alanine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Emtricitabine; Female; HIV Infections; Humans; Male; Organophosphonates; Quinolones; Tenofovir; Thiazoles

2015